Mr Eduardo Pons-Fuster Lopez

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

Follow

Contributor content

Predictive capacity of the HFA-ICOS risk stratification scale for cardiovascular adverse events in patients treated with proteasome inhibitors

Presentation

Predictive capacity of the HFA-ICOS risk stratification scale for cardiovascular adverse events in patients treated with proteasome inhibitors

ESC 365 is supported by

novartis

Explore sponsored resources